Lung Infection

Global Burden of RSV Profiled in Children Aged 0 to 60 Months in 2019

Publish Date May 24, 2022

Respiratory syncytial virus (RSV) infection contributes to substantial morbidity and mortality worldwide in children aged 0 to 60 months.

Gram Stain-Guided Antibiotics: Effective, May Combat Spread of Multidrug-Resistant Pathogens

By

Bradley van Paridon

Publish Date May 12, 2022

Researchers compared the effect of Gram stain-guided antibiotics with guideline-based antibiotics for the treatment of patients with ventilator-associated pneumonia.

Chronic Bacterial Infections Associated With an Increased Risk for Ischemic Stroke

By

Devon Cimino

Publish Date May 11, 2022

In this meta-analysis, researchers assessed the relationship between 4 infectious bacteria and the risk for ischemic stroke.

Long-COVID Lung Disease: Researchers Characterize 3 Phenotypes

By

Virginia A. Schad, PharmD, RPh

Publish Date May 5, 2022

Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?

Identifying Lung Impairment in Preschoolers With Primary Ciliary Dyskinesia

By

Pam Brick

Publish Date May 2, 2022

Can the Lung Clearance Index, which uses the multiple breath washout test, be used in preschool children to detect lung impairment from primary ciliary dyskinesia?

RSV Prefusion F Protein-Based Immunization Studied in Pregnancy

Publish Date April 29, 2022

A bivalent RSV prefusion F protein-based vaccine given during pregnancy elicits neutralizing antibody responses.

Pediatric Primary Spontaneous Pneumothorax Update

By

Ron Goldberg

Publish Date April 26, 2022

What is the best approach to managing pediatric primary spontaneous pneumothorax? To answer this, researchers reviewed recent research and real-world experience.

Exercise Limitation 3 Months Post Severe COVID-19 Lung Infection

By

Sheila Jacobs

Publish Date April 22, 2022

How often do survivors of severe COVID-19 pulmonary infection experience long-term exercise capacity limitation, and what factors are associated with this condition?

Consensus Treatment Outcome Definitions for Chronic Pulmonary Aspergillosis

By

Sheila Jacobs

Publish Date April 7, 2022

Consensus definitions for chronic pulmonary aspergillosis treatment outcomes, developed by a panel of international experts convened by CPAnet, were recently published.

RSV Vaccine Candidate for Older Adults Gets Breakthrough Therapy Designation

By

Brian Park, PharmD

Publish Date March 31, 2022

The RSVpreF vaccine candidate consists of 2 prefusion F proteins selected to optimize protection against RSV A and B.

Pediatric Trial Evaluating COVID-19 Oral Antiviral Paxlovid Begins

By

Brian Park, PharmD

Publish Date March 24, 2022

The EPIC-PEDS study will include approximately 140 patients less than 18 years of age with a confirmed diagnosis of COVID-19 who are at risk of progression to severe disease.